phenethyl isothiocyanate has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Chen, Y; Fu, X; Hao, Q; Liu, W; Wu, H; Zhang, L | 1 |
| Chen, W; Li, Y; Ma, T; Xiao, J; Xiao, Y; Ye, J; Zhang, Y; Zhou, N | 1 |
2 other study(ies) available for phenethyl isothiocyanate and transforming growth factor beta
| Article | Year |
|---|---|
Phenethyl isothiocyanate suppresses cervical carcinoma metastasis potential and its molecular mechanism.
Topics: Antineoplastic Agents; Cell Adhesion; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Gene Expression; HeLa Cells; Humans; Interleukin-6; Interleukin-8; Isothiocyanates; Neoplasm Invasiveness; Neoplasm Metastasis; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Uterine Cervical Neoplasms | 2014 |
PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT.
Topics: Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression; Humans; Isothiocyanates; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2020 |